Our aim is to find disease modifying therapies for the diseases that cause dementia.

We’re looking for targets that have been unexplored by the pharmaceutical industry, broadening our focus to novel proteins and pathways implicated in neurodegenerative diseases and will draw on academic expertise to find these.

We’re building our portfolio and we’re keen to hear from academics with new approaches. Find out more about collaborating with us on drug discovery projects.